Clinical Trials Directory

This study lasts about 34 weeks. Participants will be placed into one of two groups by chance. One group will receive a study medicine called ANB033, and the other group will receive a placebo, which has no active medicine. During the study, participants will have about 14 visits. At these visits, doctors will collect blood samples, take X rays, perform biopsies if needed, and ask participants to complete questionnaires about their health and symptoms. Researchers will use this information to learn more about the safety and effects of ANB033.

We are doing this study to learn more about how androgens, a type of sex hormone, might affect women who have nonalcoholic fatty liver disease (NAFLD). We want to see if they play a role in how the disease effects women over time, and we also want to see what role these hormones might play in the relationship between NAFLD and polycystic ovary syndrome.

This is an observational study that collects health information and samples from children, teens, and young adults with certain cancers or tumors. Participants may join one of two projects that include reviewing medical records and collecting samples such as blood, tissue, saliva, urine, or other body fluids to help researchers learn more about these diseases.

This study places pregnant women into one of two groups by chance. One group receives antibiotics when labor is started, including cefazolin through a vein and a one time dose of azithromycin. The other group receives placebo treatments that look the same but do not contain medicine. After delivery, researchers will follow up with participants during their postpartum visit or by phone or email to collect information about their health and recovery. The goal is to learn whether giving these antibiotics during labor can improve outcomes for mothers and babies.